NutriBand Inc. (NTRB) Earnings Signals & AI Vibe Check

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, NutriBand Inc.'s filing signal turned positive.

Nutriband Inc. is a Nevada-based pharmaceutical company focused on developing a portfolio of transdermal drug delivery products, primarily utilizing its proprietary AVERSATM abuse-deterrent transdermal technology. This technology aims to prevent the abuse, misuse, and accidental exposure of drugs with abuse potential, such as opioids and stimulants, by incorporating aversive agents into transdermal patches. The company's lead product candidate is AVERSATM Fentanyl, with other pipeline products including AVERSATM Buprenorphine and AVERSATM Methylphenidate. Nutriband operates through two subsidiaries: Pocono Pharmaceuticals, which provides contract manufacturing services for health and wellness products, and 4P Therapeutics, which offers contract research and development services. The company primarily operates and derives revenue in the United States.

Revenue is generated through contract manufacturing services provided by Pocono Pharmaceuticals and contract research and development services from 4P Therapeutics. The company's primary focus, however, is on the development of its proprietary transdermal pharmaceutical products, which are not yet generating significant revenue.